Cancer diagnostics company Pacific Edge is maintaining momentum thanks to a record first quarter.
In a market update ahead of its annual meeting today, the listed biotech said it had delivered its best three months to June 30 in both throughput and cash receipts.
Laboratory throughput for the
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
